Investing

Editor's Top Picks

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form Investing

Buying a Home Is Getting Out of Reach. Those 7% Mortgage Rates Are Why.

Anyone looking to venture into the housing market got whacked with another jump in mortgage

Opinion: Carbon data needs fixing or climate-aware investments may fall short

It’s no secret that the world’s business and policymaking establishment adopted carbon penalties and offsets

Margot Robbie hit it big with a $50 million ‘Barbie’ payday, but what about other actresses?

Call it a “Barbie” bonanza: Margot Robbie, the star of the blockbuster film, is in

Unilever CEO vows to look at Russian operations with ‘fresh eyes’ as pressure to exit the country mounts

Consumer goods giant Unilever PLC is coming under renewed pressure to exit Russia following recent

Palo Alto Networks CEO addresses Friday earnings experiment: ‘Lesson learnt’

“Lesson learnt :)” — Nikesh Arora, Palo Alto Networks CEO After spooking Wall Street for

‘Magnificent Seven’ stocks are losing some of their shine, but their bonds are doing fine

The so-called Magnificent Seven grouping of technology stocks lost some of its luster this week after

China Evergrande has $28.1 billion of outstanding bonds as it files for Chapter 15 bankruptcy

China Evergrande Group, which filed for Chapter 15 bankruptcy protection in New York late Thursday,

As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant

Amid an uptick in COVID-19 hospitalizations, vaccine makers say the updated shots they’ve developed for

The Apple Watch may now be a back-to-school necessity

As kids go back to school, more of them are wearing Apple Watches with the

Gold ends higher for the first time in 10 sessions

Gold futures settled higher Friday for the first time in 10 trading sessions, putting an

Oil prices post first weekly loss since June

Oil futures ended higher Friday, but tallied their first weekly loss in eight weeks as

Neurocrine Biosciences’ Ingrezza Gets FDA Approval

By Brenda León Neurocrine Biosciences said Friday the Food and Drug Administration approved Ingrezza capsules

Maui Land & Pineapple Shares Down 4% on 2Q Loss; Holdings Undamaged by Wildfire

By Brenda León Maui Land & Pineapple shares fell in post-market trading on Friday after

ElectraMeccanica Won’t Pursue Project E4 for Passenger Vehicle

By Josh Beckerman ElectraMeccanica, which previously said its merger with Tevva represented a pivot to

Regeneron Pharmaceuticals Gets FDA OK for High-Dose Eylea Eye Treatment

By Will Feuer Regeneron Pharmaceuticals said the Food and Drug Administration has approved an eight-milligram